Zonisamide-induced weight loss in schizophrenia: Case series

Jaewon Yang, Moon Soo Lee, Sook Haeng Joe, In Kwa Jung, Seung Hyun Kim

    Research output: Contribution to journalArticlepeer-review

    7 Citations (Scopus)


    Weight gain and metabolic disturbances constitute bothersome problems in schizophrenic patients treated with atypical antipsychotics. Several medications, exercise regimens, and lifestyle changes have been used in attempts to ameliorate these problems. We describe 3 patients with schizophrenia who manifested distinct weight loss and reduction in waist circumference during medication with zonisamide. This report suggests that zonisamide might be associated with weight loss in patients with schizophrenia.

    Original languageEnglish
    Pages (from-to)104-106
    Number of pages3
    JournalClinical Neuropharmacology
    Issue number2
    Publication statusPublished - 2010 Mar


    • Obesity
    • Schizophrenia
    • Waist circumference
    • Weight loss
    • Zonisamide

    ASJC Scopus subject areas

    • Pharmacology
    • Clinical Neurology
    • Pharmacology (medical)


    Dive into the research topics of 'Zonisamide-induced weight loss in schizophrenia: Case series'. Together they form a unique fingerprint.

    Cite this